Lazanda
Product Images NDC 51772-314

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Lazanda (NDC 51772-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Archimedes Pharma Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flow Chart (Lazanda 01)

This text describes the titration process for Lazanda, a medication for pain relief that is administered through the nostrils. The starting dose is 100 meg and the user is instructed to wait at least two hours before using it again for the next episode of pain. The user is asked to evaluate the pain relief after 30 minutes and based on the response, instructions are given to either use the same dose for the next pain episode or increase to a higher dose following the titration steps described. The successful dose is the one that provides adequate pain relief.*

FDA Label Image

Chemical Structure (Lazanda 02)

FDA Label Image

Fig 1 (Lazanda 03)

FDA Label Image

Fig 2 (Lazanda 04)

FDA Label Image

Figure (Lazanda 05)

FDA Label Image

Figure (Lazanda 06)

FDA Label Image

Figure (Lazanda 07)

FDA Label Image

Figure (Lazanda 08)

FDA Label Image

Figure (Lazanda 09)

FDA Label Image

Figure (Lazanda 10)

FDA Label Image

Figure (Lazanda 11)

FDA Label Image

Figure (Lazanda 12)

FDA Label Image

Figure (Lazanda 13)

FDA Label Image

Figure (Lazanda 14)

FDA Label Image

Figure (Lazanda 15)

FDA Label Image

Principal Display Panel (100 mcg Carton)

This is a medication guide for Lazanda, a fentanyl nasal spray used for pain relief. The product is dispensed in 4 bottles containing 8 sprays each and must be administered via nasal administration. Patients must read the enclosed Medication Guide before use. Lazanda is for patients who are tolerant to around-the-clock opioid therapy and must not be substituted for other fentanyl products. The product is sensitive and could be harmful or fatal if given to someone for whom it was not prescribed. Lazanda is available only through a restricted distribution program called the TIRF REMS Access program, and users can contact 1.866822-1483 or TIRFREMSaccess.com for more information.*

FDA Label Image

Principal Display Panel (400 mcg Carton)

This is a medication guide for Lazanda, a fentanyl nasal spray used around the clock for opioid therapy. The enclosed Medication Guide contains important warnings and instructions, and patients must be tolerant of around-the-clock opioid therapy. Lazanda is only available through a restricted distribution program called the TIRF REMS ACCESS program. The prescription must be given with caution, and the patients must be informed about the use of the product including the Verification Guide. The chemical details and dosage recommendations are enclosed, along with information on storage and precautions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.